Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1995 Aug;57(2):321–328.

Analysis of phenotypic features and FGFR2 mutations in Apert syndrome.

W J Park 1, C Theda 1, N E Maestri 1, G A Meyers 1, J S Fryburg 1, C Dufresne 1, M M Cohen Jr 1, E W Jabs 1
PMCID: PMC1801532  PMID: 7668257

Abstract

A phenotypic and genotypic survey was conducted on 36 Apert syndrome patients. In all but one patient, an FGFR2 mutation, either S252W or P253R, was found in exon IIIa (exon U or 7). The frequency was 71% and 26%, for the mutations S252W and P253R, respectively. These mutations occur in the linker region between immunoglobulin-like domains II and III, which are involved in activation of the receptor by ligand binding and dimerization. The fact that one patient did not have a mutation in the same exon suggests further genetic heterogeneity in Apert syndrome. The frequencies of occurrence or means for measurements of 29 different clinical features (including severity of craniofacial features, syndactyly of the hands and feet, and multisystem involvement) were determined for all patients and for the two subgroups defined by their mutations. Comparison between the subgroups for the different clinical features was performed and suggested no statistically significant differences. These results are not unexpected, because the two common mutations for Apert syndrome alter FGFR2 at adjacent amino acids that are likely to have similar biological, and therefore phenotypic, consequences.

Full text

PDF
321

Images in this article

323Figure 2
on p.323
324Figure 3
on p.324
325Figure 4
on p.325

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allanson J. E. Germinal mosaicism in Apert syndrome. Clin Genet. 1986 May;29(5):429–433. doi: 10.1111/j.1399-0004.1986.tb00516.x. [DOI] [PubMed] [Google Scholar]
  2. Bellus G. A., Hefferon T. W., Ortiz de Luna R. I., Hecht J. T., Horton W. A., Machado M., Kaitila I., McIntosh I., Francomano C. A. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet. 1995 Feb;56(2):368–373. [PMC free article] [PubMed] [Google Scholar]
  3. Cohen M. M., Jr, Kreiborg S., Lammer E. J., Cordero J. F., Mastroiacovo P., Erickson J. D., Roeper P., Martínez-Frías M. L. Birth prevalence study of the Apert syndrome. Am J Med Genet. 1992 Mar 1;42(5):655–659. doi: 10.1002/ajmg.1320420505. [DOI] [PubMed] [Google Scholar]
  4. Cohen M. M., Jr, Kreiborg S. The central nervous system in the Apert syndrome. Am J Med Genet. 1990 Jan;35(1):36–45. doi: 10.1002/ajmg.1320350108. [DOI] [PubMed] [Google Scholar]
  5. Cohn M. S., Mahon M. J. Apert's syndrome (acrocephalosyndactyly) in a patient with hyperhidrosis. Cutis. 1993 Oct;52(4):205–208. [PubMed] [Google Scholar]
  6. Dionne C. A., Crumley G., Bellot F., Kaplow J. M., Searfoss G., Ruta M., Burgess W. H., Jaye M., Schlessinger J. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 1990 Sep;9(9):2685–2692. doi: 10.1002/j.1460-2075.1990.tb07454.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Erickson J. D., Cohen M. M., Jr A study of parental age effects on the occurrence of fresh mutations for the Apert syndrome. Ann Hum Genet. 1974 Jul;38(1):89–96. doi: 10.1111/j.1469-1809.1974.tb01996.x. [DOI] [PubMed] [Google Scholar]
  8. Givol D., Yayon A. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J. 1992 Dec;6(15):3362–3369. [PubMed] [Google Scholar]
  9. Jabs E. W., Li X., Scott A. F., Meyers G., Chen W., Eccles M., Mao J. I., Charnas L. R., Jackson C. E., Jaye M. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet. 1994 Nov;8(3):275–279. doi: 10.1038/ng1194-275. [DOI] [PubMed] [Google Scholar]
  10. Jones E. Y., Davis S. J., Williams A. F., Harlos K., Stuart D. I. Crystal structure at 2.8 A resolution of a soluble form of the cell adhesion molecule CD2. Nature. 1992 Nov 19;360(6401):232–239. doi: 10.1038/360232a0. [DOI] [PubMed] [Google Scholar]
  11. Lajeunie E., Ma H. W., Bonaventure J., Munnich A., Le Merrer M., Renier D. FGFR2 mutations in Pfeiffer syndrome. Nat Genet. 1995 Feb;9(2):108–108. doi: 10.1038/ng0295-108. [DOI] [PubMed] [Google Scholar]
  12. Lewanda A. F., Cohen M. M., Jr, Hood J., Morsey S., Walters M., Kennedy J. L., Jr, Jabs E. W. Cytogenetic survey of Apert syndrome. Reevaluation of a translocation (2;9)(p11.2;q34.2) in a patient suggests the breakpoints are not related to the disorder. Am J Dis Child. 1993 Dec;147(12):1306–1308. doi: 10.1001/archpedi.1993.02160360048016. [DOI] [PubMed] [Google Scholar]
  13. Miki T., Bottaro D. P., Fleming T. P., Smith C. L., Burgess W. H., Chan A. M., Aaronson S. A. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):246–250. doi: 10.1073/pnas.89.1.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Muenke M., Schell U., Hehr A., Robin N. H., Losken H. W., Schinzel A., Pulleyn L. J., Rutland P., Reardon W., Malcolm S. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet. 1994 Nov;8(3):269–274. doi: 10.1038/ng1194-269. [DOI] [PubMed] [Google Scholar]
  15. Mulvihill J. J. Craniofacial syndromes: no such thing as a single gene disease. Nat Genet. 1995 Feb;9(2):101–103. doi: 10.1038/ng0295-101. [DOI] [PubMed] [Google Scholar]
  16. Reardon W., Winter R. M., Rutland P., Pulleyn L. J., Jones B. M., Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet. 1994 Sep;8(1):98–103. doi: 10.1038/ng0994-98. [DOI] [PubMed] [Google Scholar]
  17. Rommens J. M., Iannuzzi M. C., Kerem B., Drumm M. L., Melmer G., Dean M., Rozmahel R., Cole J. L., Kennedy D., Hidaka N. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989 Sep 8;245(4922):1059–1065. doi: 10.1126/science.2772657. [DOI] [PubMed] [Google Scholar]
  18. Rutland P., Pulleyn L. J., Reardon W., Baraitser M., Hayward R., Jones B., Malcolm S., Winter R. M., Oldridge M., Slaney S. F. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet. 1995 Feb;9(2):173–176. doi: 10.1038/ng0295-173. [DOI] [PubMed] [Google Scholar]
  19. Schell U., Hehr A., Feldman G. J., Robin N. H., Zackai E. H., de Die-Smulders C., Viskochil D. H., Stewart J. M., Wolff G., Ohashi H. Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Hum Mol Genet. 1995 Mar;4(3):323–328. doi: 10.1093/hmg/4.3.323. [DOI] [PubMed] [Google Scholar]
  20. Shiang R., Thompson L. M., Zhu Y. Z., Church D. M., Fielder T. J., Bocian M., Winokur S. T., Wasmuth J. J. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 1994 Jul 29;78(2):335–342. doi: 10.1016/0092-8674(94)90302-6. [DOI] [PubMed] [Google Scholar]
  21. Tavormina P. L., Shiang R., Thompson L. M., Zhu Y. Z., Wilkin D. J., Lachman R. S., Wilcox W. R., Rimoin D. L., Cohn D. H., Wasmuth J. J. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet. 1995 Mar;9(3):321–328. doi: 10.1038/ng0395-321. [DOI] [PubMed] [Google Scholar]
  22. Upton J. Apert syndrome. Classification and pathologic anatomy of limb anomalies. Clin Plast Surg. 1991 Apr;18(2):321–355. [PubMed] [Google Scholar]
  23. Wilkie A. O., Slaney S. F., Oldridge M., Poole M. D., Ashworth G. J., Hockley A. D., Hayward R. D., David D. J., Pulleyn L. J., Rutland P. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet. 1995 Feb;9(2):165–172. doi: 10.1038/ng0295-165. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES